HOME >> BIOLOGY >> NEWS
Old drug shows new promise for Huntington's Disease

se as a potential treatment for Alzheimer's disease in recent studies in mice and humans. Apparently through chelation, it interferes with the creation of beta-amyloid plaque in the brain, which has been implicated in the progression of Alzheimer's symptoms.

Currently, Clioquinol is banned for internal use in many countries because of its side effects. In Japan in the late 1950s and 60s, the drug was found to cause a neurologic condition called subacute myelo-optico-neuropathy (SMON), with symptoms including visual loss, muscle weakness, and numbness, in several thousand people. However, noted Massa, the doses given in current clinical trials are much smaller than were commonly prescribed in Japan. In addition, he explained, it has been found that vitamin B12, when taken along with the drug, protects against its potential toxic effects.

Co-authors of the study were Trent Nguyen, PhD, and Aaron Hamby, BS, of SFVAMC and UCSF.


'"/>

Contact: Steve Tokar
steve.tokar@ncire.org
415-221-4810 x5202
University of California - San Francisco
11-Sep-2005


Page: 1 2 3

Related biology news :

1. Clones on task serve greater good, evolutionary study shows
2. Research shows skeleton to be endocrine organ
3. An early ape shows its hand
4. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
5. Huntingtons disease study shows animal models on target
6. Research shows NPD1 protects a key component of vision
7. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
8. Chitin from lobster shell shows great healing and bio-stimulant properties
9. Study shows cane sugar, corn sweeteners have similar effects on appetite
10. New research shows vaginal bacteria vary among healthy women, need customized treatment
11. Global warming is evaporating Arctic ponds, new study shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2020)... (PRWEB) , ... January 21, 2020 , ... ... Pozil to lead the company’s new Business Development Department. The move, which is ... Pozil had been previously serving as the company’s Senior Vice President where he ...
(Date:1/10/2020)... , ... January 09, 2020 , ... ... bioactive spinal solutions, today announced the 510(K) clearance and commercial launch of the ... interbody fusion system. , The EVOL®ha-DLIF is made of PEEK-OPTIMA HA Enhanced ...
(Date:1/7/2020)... ... January 06, 2020 , ... Myant Inc. , the ... Las Vegas) to bring to life its vision of a world where textile-based interfaces ... community, the AI-powered digital sphere, and the physical IoT-enabled environment. The experience at Myant’s ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... Lifecycle Biotechnologies announced ... beverage manufactures within North America. Both Lifecycle and Midland have supported this industry ... company to pool their collective resources and provide the industry with support, service, ...
(Date:1/24/2020)... ... , ... The plastic and reconstructive surgeons at The Institute for Advanced ... that plastic surgery is much more than just cosmetic surgery and far more extensive ... 20 years NJ Top Docs, Dr. Andrew Elkwood, Dr. Michael Rose, Dr. Matthew Kaufman, ...
(Date:1/22/2020)... (PRWEB) , ... January 21, 2020 , ... ... hiring of Darrell Taylor as Southern Midwest Region Industrial and Institutional (I&I) Account ... SporActiv™ product line. , Darrell brings over 30 years of sales ...
(Date:1/10/2020)... PISCATAWAY, N.J. (PRWEB) , ... January 09, 2020 ... ... companies in China, today announced its inaugural GenScript Biotech Global Forum on Jan. ... Forum, exploring the theme "Cell and Gene Therapy and the Booming China Market," ...
Breaking Biology Technology:
Cached News: